Canada Gairdner Awards honour RI-MUHC researcher Dr. Isabelle Malhamé
Early career researcher investigates maternal morbidity across the pregnancy continuum
Source: RI-MUHC.
Dr. Isabelle Malhamé of the Research Institute of the McGill University Health Centre (RI‑MUHC) has received a Gairdner Early Career Investigator Award from the Gairdner Foundation and the Canada Gairdner Awards.
The Gairdner Early Career Investigator Award invites promising Canadian researchers to submit research summaries for consideration by the Canada Gairdner Award winners, who select their top candidates. Winners join the laureates in Toronto for Gairdner Science Week to present their own research to an international audience, build new scientific connections, and represent the exceptional work being done at all levels of the Canadian research ecosystem. Dr. Malhamé, a junior scientist in the Cardiovascular Health Across the Lifespan Program at the RI-MUHC, was selected by Gairdner Award laureate Dr. Zulfiqar Bhutta for her research on severe maternal morbidity across the pregnancy continuum.
“I am deeply grateful to the Gairdner Foundation for bringing maternal and perinatal research to the forefront this year. It is an honour to be able to share the progress and future direction of the work we are conducting at the RI-MUHC to reduce severe maternal morbidity, including from cardiovascular and thromboembolic complications,” says Dr. Malhamé.
Dr. Malhamé’s research program focuses on early detection and prevention of maternal morbidity events, innovation in the management of high-risk conditions in pregnancy, and quality improvement initiatives to optimize the care of pregnant and postpartum individuals. She conducts research at the Centre for Outcomes Research and Evaluation at the RI-MUHC.
Congratulations, Dr. Malhamé!
Learn more about the Gairdner Foundation and the Canada Gairdner Awards
Read Dr. Malhamé’s recent publication, Cardiovascular Severe Maternal Morbidity and Mortality at Delivery in the United States: A Population-Based Study.
October 27, 2022